| Patient | Theodore Roosevelt |
|---|---|
| Date of birth | 1858-10-27 |
| Identifiers | MRN HR-NI012-SYN-TD; SSN (made up) 000-12-6157 |
| Document date | 2026-11-01 |
| Author | Amos Kettering, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Primary care visit for frequent wheeze, night cough, and breathlessness during training. Concerns: Wheeze, night cough, and breathlessness are limiting his training and his long days at work; Would rather control his asthma with exercise than with daily medicine. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Albuterol 90 mcg/actuation inhaler, two inhalations as needed for wheeze (bought after an urgent care visit; used most days before intake) | Two inhalations every 4 hours as needed | Respiratory tract route | 1881-12-15 to 1882-03-09 | stopped | S |
| Budesonide-formoterol 160/4.5 mcg inhaler, two inhalations twice daily for maintenance | Two inhalations twice daily, with a spacer, rinsing the mouth afterwards | Respiratory tract route | 1882-03-09 | active | S |
| Budesonide-formoterol 160/4.5 mcg inhaler, one inhalation as needed for symptoms and before exercise; no more than 12 inhalations a day in total | One inhalation as needed, repeated after a few minutes if needed; maximum 12 inhalations a day including maintenance doses | Respiratory tract route | 1882-03-09 | active | S |
| Prednisone 20 mg oral tablet, two tablets (40 mg) by mouth each morning for 5 days | Two tablets by mouth each morning for 5 days | Oral route | 1882-08-03 to 1882-08-07 | completed | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Spirometry before and after albuterol 400 mcg: FEV1 3.20 L (72 percent predicted), FEV1/FVC 0.67, FEV1 rising to 3.74 L after bronchodilator | 1882-03-09 to 1882-03-09 | completed | S |
| Written asthma action plan with symptom and peak-flow zones; peak flow meter issued | 1882-03-09 to 1882-03-09 | completed | S |
| Spirometry after three months of controller therapy: FEV1 3.98 L (89 percent predicted), FEV1/FVC 0.79 | 1882-06-08 to 1882-06-08 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1881-10-14 | Influenza vaccine, 1881-1882 season | completed | S |
| 1875-08-12 | Tdap vaccine | completed | S |
| 1870-04-07 | HPV 9-valent vaccine, two-dose series completed | completed | S |
| 1882-04-06 | Pneumococcal conjugate vaccine PCV20 | completed | S |
| 1882-10-19 | Influenza vaccine, 1882-1883 season | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1860s | Severe childhood asthma, with night attacks in which he sat up in bed gasping, and trips away from home to find a place where he could breathe | D (CLM-0002) |
| 1872 | Near-sightedness discovered at about thirteen; first spectacles | D (CLM-0004) |
| 1872 | Asthma attack at nearly fourteen, after which he was sent to Moosehead Lake and began boxing and a program of physical training | D (CLM-0003) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| father | Died in 1878, shortly after a diagnosis of stomach cancer | D (CLM-0007) |
| Concern | Status | Evidence |
|---|---|---|
| Wheeze, night cough, and breathlessness are limiting his training and his long days at work | active | S |
| Would rather control his asthma with exercise than with daily medicine | active | S |
Most recent measures: FEV1 --pre bronchodilation 3.2 on 1882-03-09; FEV1 measured/predicted 89 on 1882-06-08; Forced vital capacity [Volume] Respiratory system 5.02 on 1882-06-08; FEV1/FVC 0.79 on 1882-06-08; FEV1 --post bronchodilation 3.74 on 1882-03-09; Total score [ACT] 21 on 1882-09-14; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1882-10-19; Fractional concentration of exhaled nitric oxide 46 on 1882-04-06; Eosinophils [#/volume] in Blood by Automated count 0.42 on 1882-04-06; IgE [Units/volume] in Serum or Plasma 260 on 1882-04-06; European house dust mite IgE Ab [Units/volume] in Serum 8.4 on 1882-04-06; FEV1 3.98 on 1882-06-08; Maximum expiratory gas flow Respiratory system airway by Peak flow meter 420 on 1882-08-03; Total score [AUDIT-C] 1 on 1882-10-19 [S]
Strengths and supports: Supports: close friends, a boxing coach, and colleagues at work [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Moderate persistent asthma, uncontrolled at intake, with reversible airflow obstruction on spirometry; synthetic modern diagnosis linked to his documented lifelong asthma | active | confirmed | J45.40 | S — Synthetic modern classification confirmed by spirometry; the historical asthma is D and its persistence into adulthood is R. |
| Myopia, both eyes, corrected with glasses since boyhood | active | confirmed | H52.13 | S — Synthetic modern entry linked to his documented near-sightedness. |
| Moderate asthma exacerbation triggered by a viral cold, treated in the office with a five-day prednisone course; resolved | resolved | confirmed | J45.41 | S — Synthetic exacerbation at an unscheduled visit; viral infection is the most common trigger of asthma exacerbations. It does not echo a dated historical episode. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1882-03-09 | FEV1 --pre bronchodilation | 3.2 | L | >=3.65 L | Low | S |
| 1882-03-09 | FEV1 measured/predicted | 72 | % | >=80% | Low | S |
| 1882-03-09 | Forced vital capacity [Volume] Respiratory system | 4.8 | L | >=4.4 L | Normal | S |
| 1882-03-09 | FEV1/FVC | 0.67 | {ratio} | >=0.72 | Low | S |
| 1882-03-09 | FEV1 --post bronchodilation | 3.74 | L | >=3.65 L | Normal | S |
| 1882-03-09 | Total score [ACT] | 13 | {score} | S | ||
| 1882-03-09 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 1882-04-06 | Total score [ACT] | 18 | {score} | S | ||
| 1882-04-06 | Fractional concentration of exhaled nitric oxide | 46 | [ppb] | <=25 [ppb] | High | S |
| 1882-04-06 | Eosinophils [#/volume] in Blood by Automated count | 0.42 | 10*3/uL | 0-0.5 10*3/uL | Normal | S |
| 1882-04-06 | IgE [Units/volume] in Serum or Plasma | 260 | [IU]/mL | <=100 [IU]/mL | High | S |
| 1882-04-06 | European house dust mite IgE Ab [Units/volume] in Serum | 8.4 | k[IU]/L | <=0.35 k[IU]/L | High | S |
| 1882-06-08 | FEV1 | 3.98 | L | >=3.65 L | Normal | S |
| 1882-06-08 | FEV1 measured/predicted | 89 | % | >=80% | Normal | S |
| 1882-06-08 | Forced vital capacity [Volume] Respiratory system | 5.02 | L | >=4.4 L | Normal | S |
| 1882-06-08 | FEV1/FVC | 0.79 | {ratio} | >=0.72 | Normal | S |
| 1882-06-08 | Maximum expiratory gas flow Respiratory system airway by Peak flow meter | 605 | L/min | 80 percent or more of his personal best of 610 L/min (green zone) | Normal | S |
| 1882-06-08 | Total score [ACT] | 22 | {score} | S | ||
| 1882-09-14 | Maximum expiratory gas flow Respiratory system airway by Peak flow meter | 590 | L/min | 80 percent or more of his personal best of 610 L/min (green zone) | Normal | S |
| 1882-09-14 | Total score [ACT] | 21 | {score} | S | ||
| 1882-08-03 | Maximum expiratory gas flow Respiratory system airway by Peak flow meter | 420 | L/min | 80 percent or more of his personal best of 610 L/min (green zone) | Low | S |
| 1882-10-19 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 1882-10-19 | Total score [AUDIT-C] | 1 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1882-03-09 | Body height | 175 | cm | S |
| 1882-03-09 | Body weight | 72 | kg | S |
| 1882-03-09 | Body mass index (BMI) [Ratio] | 23.5 | kg/m2 | S |
| 1882-03-09 | Systolic blood pressure | 118 | mm[Hg] | S |
| 1882-03-09 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1882-03-09 | Heart rate | 84 | /min | S |
| 1882-03-09 | Respiratory rate | 18 | /min | S |
| 1882-03-09 | Body temperature | 36.8 | Cel | S |
| 1882-03-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| 1882-04-06 | Body height | 175 | cm | S |
| 1882-04-06 | Body weight | 72.4 | kg | S |
| 1882-04-06 | Body mass index (BMI) [Ratio] | 23.6 | kg/m2 | S |
| 1882-04-06 | Systolic blood pressure | 116 | mm[Hg] | S |
| 1882-04-06 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1882-04-06 | Heart rate | 76 | /min | S |
| 1882-04-06 | Respiratory rate | 16 | /min | S |
| 1882-04-06 | Body temperature | 36.7 | Cel | S |
| 1882-04-06 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1882-06-08 | Body height | 175 | cm | S |
| 1882-06-08 | Body weight | 73 | kg | S |
| 1882-06-08 | Body mass index (BMI) [Ratio] | 23.8 | kg/m2 | S |
| 1882-06-08 | Systolic blood pressure | 118 | mm[Hg] | S |
| 1882-06-08 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1882-06-08 | Heart rate | 70 | /min | S |
| 1882-06-08 | Respiratory rate | 14 | /min | S |
| 1882-06-08 | Body temperature | 36.6 | Cel | S |
| 1882-06-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1882-09-14 | Body height | 175 | cm | S |
| 1882-09-14 | Body weight | 73.2 | kg | S |
| 1882-09-14 | Body mass index (BMI) [Ratio] | 23.9 | kg/m2 | S |
| 1882-09-14 | Systolic blood pressure | 116 | mm[Hg] | S |
| 1882-09-14 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1882-09-14 | Heart rate | 68 | /min | S |
| 1882-09-14 | Respiratory rate | 14 | /min | S |
| 1882-09-14 | Body temperature | 36.7 | Cel | S |
| 1882-09-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1882-08-03 | Body height | 175 | cm | S |
| 1882-08-03 | Body weight | 72.2 | kg | S |
| 1882-08-03 | Body mass index (BMI) [Ratio] | 23.6 | kg/m2 | S |
| 1882-08-03 | Systolic blood pressure | 122 | mm[Hg] | S |
| 1882-08-03 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1882-08-03 | Heart rate | 98 | /min | S |
| 1882-08-03 | Respiratory rate | 20 | /min | S |
| 1882-08-03 | Body temperature | 37.6 | Cel | S |
| 1882-08-03 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 | % | S |
| 1882-10-19 | Body height | 175 | cm | S |
| 1882-10-19 | Body weight | 73.5 | kg | S |
| 1882-10-19 | Body mass index (BMI) [Ratio] | 24 | kg/m2 | S |
| 1882-10-19 | Systolic blood pressure | 118 | mm[Hg] | S |
| 1882-10-19 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1882-10-19 | Heart rate | 66 | /min | S |
| 1882-10-19 | Respiratory rate | 14 | /min | S |
| 1882-10-19 | Body temperature | 36.6 | Cel | S |
| 1882-10-19 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1882-03-09 | Primary care visit for frequent wheeze, night cough, and breathlessness during training | finished | S |
| 1882-04-06 | Four-week asthma review after starting maintenance-and-reliever therapy, with pulmonology consultation | finished | S |
| 1882-06-08 | Three-month asthma review with repeat spirometry | finished | S |
| 1882-09-14 | Six-month asthma review after a summer exacerbation | finished | S |
| 1882-08-03 | Same-day sick visit for wheeze and chest tightness with a cold | finished | S |
| 1882-10-19 | Periodic adult preventive visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Stop reliever-only albuterol and start budesonide-formoterol maintenance-and-reliever therapy at Step 4 (two inhalations twice daily plus one as needed, up to 12 a day), with a spacer and inhaler-technique teaching | completed | GL-GINA-2025, GL-NAEPP-2020 | S |
| Written asthma action plan with symptom and peak-flow zones (green 80 percent or more of personal best, yellow 50 to 79 percent, red below 50 percent), reviewed at every visit and after every exacerbation | completed | GL-CMID-2026, GL-GINA-2025, GL-NAEPP-2020 | S |
| Pulmonology referral to confirm the diagnosis, assess type 2 inflammation, and advise on exercise-induced symptoms, allergen measures, and treatment step | completed | GL-GINA-2025, GL-NAEPP-2020 | S |
| Asthma Control Test, inhaler technique, adherence, reliever use, triggers, and exacerbation history at every visit; review one to three months after starting controller therapy, then every three to twelve months, and within one week of any exacerbation; spirometry at diagnosis, three to six months after stabilization, then every one to two years | completed | GL-CMID-2026, GL-GINA-2025, GL-NAEPP-2020 | S |
| Explain that exercise improves fitness but does not treat airway inflammation; take one reliever inhalation before boxing or rowing; use dust-mite-impermeable bedding covers once sensitization is shown | completed | GL-NAEPP-2020, GL-GINA-2025 | S |
| Yearly influenza vaccine, pneumococcal vaccination for chronic lung disease, and COVID-19 vaccination by CDC guidance | completed | GL-CMID-2026, GL-ACIP-PNEUMO | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Asthma Control Test score of 20 or more by the three-month review | 1882-06-08 | completed | ACT rose from 13 to 22 | S |
| FEV1 of 80 percent predicted or more on spirometry after stabilization | 1882-06-08 | completed | FEV1 89 percent predicted with a normal FEV1/FVC ratio | S |
| No exacerbation needing oral corticosteroids over the six months after starting controller therapy | 1882-09-14 | active | Not met: one moderate exacerbation with a cold in August needed a five-day prednisone course; the goal continues for the next six months | S |
| Return to full boxing and rowing training without limiting symptoms | 1882-06-08 | completed | Training fully by the three-month review, using one reliever inhalation before sessions | S |